about
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and i...
Read More
0.76
0.01
(1.33%)
44,384
XNAS Volume
XNAS 14 Jul, 2025 1:13 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Palisade Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..